Literature DB >> 478047

Beta-carotene in erythropoietic protoporphyria: 5 years' experience.

K Thomsen, H Schmidt, A Fischer.   

Abstract

36 patients from 19 families with erythropoietic protoporphyria were treated for about 5 years during the summer months with beta-carotene alone or beta-carotene plus canthaxanthin in daily doses of 50-200 mg. The effect of the treatment was evaluated clinically on the basis of information provided by the patients regarding the period of time they could stay in the sun. 18 patients became completely free of symptoms, 16 patients improved to some extent, and 2 patients noted a slight effect. Apart from the carotenaemia, no side-effects were recorded.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478047     DOI: 10.1159/000250566

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  2 in total

Review 1.  Carotenoids.

Authors:  Billy R Hammond; Lisa M Renzi
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

2.  Variable effects of beta-carotene therapy in a child with erythropoietic protoporphyria.

Authors:  Ramin Alemzadeh; Tammy Feehan
Journal:  Eur J Pediatr       Date:  2004-07-06       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.